scholarly article | Q13442814 |
P356 | DOI | 10.1017/S0195941700057829 |
P698 | PubMed publication ID | 6404852 |
P2093 | author name string | Wormser GP | |
Donath J | |||
Tatz J | |||
P2860 | cites work | Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates | Q33725282 |
Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia Infections | Q34965193 | ||
Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients | Q34988087 | ||
Emergence of gentamicin-resistant Klebsiella in a general hospital | Q36459278 | ||
Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital | Q36470583 | ||
Interpretation of the Disk Diffusion Susceptibility Test for Amikacin: Report of a Collaborative Study | Q36479069 | ||
Review of 152 patients with bacteremias treated with amikacin | Q41020468 | ||
Patterns and Mechanisms of Emergence of Resistance to Amikacin | Q41317147 | ||
Hospital infection by multi-resistant gram-negative bacilli | Q43866727 | ||
Epidemiological studies of aminoglycoside resistance in the U.S.A | Q44200596 | ||
Bacterial Resistance to Aminoglycoside Antibiotics | Q44548828 | ||
Changing Ecology of Bacterial Infections as Related to Antibacterial Therapy | Q51228682 | ||
In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria. | Q54560177 | ||
Characteristics of gentamicin resistance in nosocomial infections. | Q54562795 | ||
Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976 | Q54596897 | ||
Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria | Q54596904 | ||
The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides | Q66925205 | ||
Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods | Q68208050 | ||
Choice of an aminoglycoside | Q71213001 | ||
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms | Q71497534 | ||
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions | Q104749539 | ||
P433 | issue | 2 | |
P921 | main subject | amikacin | Q408529 |
P304 | page(s) | 93-99 | |
P577 | publication date | 1983-03-01 | |
P1433 | published in | Infection Control | Q24091431 |
P1476 | title | Endemic resistance to amikacin among hospital isolates of gram-negative bacilli: implications for therapy | |
P478 | volume | 4 |
Q45188564 | A nursery outbreak of multiple-aminoglycoside-resistant Escherichia coli |
Q37271348 | Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. |
Q70389020 | Bacteremia in a Swedish university hospital: a one-year prospective study in 1981 and a comparison with 1975-76 |
Q35650122 | Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa |
Q35876703 | Infections in intensive care patients: use of new B-lactams. |
Q73397897 | [Impact of initial antibiotic therapy on the course of resistance to fluoroquinolones and aminoglycosides in Gram-negative bacilli isolated from intensive care patients] |
Search more.